Kane Robert L, Roebuck-Spencer Tresa, Short Paul, Kabat Michael, Wilken Jeffrey
VA Maryland Healthcare System, United States.
Arch Clin Neuropsychol. 2007 Feb;22 Suppl 1:S115-26. doi: 10.1016/j.acn.2006.10.006. Epub 2006 Nov 13.
In this article we review studies in which Automated Neuropsychological Assessment Metrics (ANAM) measures were used to screen for impairment in various clinical populations. These clinical groups include patients with multiple sclerosis, systemic lupus erythematosus, Parkinson's disease, Alzheimer's dementia, acquired brain injury, and migraine headache. Data are also presented from a group of outpatient referrals unselected with respect to clinical condition. Findings support the use of ANAM as a screening procedure for identifying the impaired patient.
在本文中，我们回顾了一些研究，这些研究使用自动化神经心理评估指标（ANAM）来筛查各种临床人群中的损伤情况。这些临床群体包括多发性硬化症、系统性红斑狼疮、帕金森病、阿尔茨海默病痴呆、获得性脑损伤和偏头痛患者。还展示了一组未根据临床状况进行选择的门诊转诊患者的数据。研究结果支持将ANAM用作识别受损患者的筛查程序。
